GNH USA

Europe — EMA

Metoject Pen

GNH USA supplies Metoject Pen (Methotrexate), a disease‑modifying antirheumatic drug for rheumatoid arthritis, psoriasis and selected leukemias or lymphomas.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Metoject Pen, is an antimetabolite presented as a pre‑filled pen for subcutaneous injection use. It is employed to treat rheumatoid arthritis, psoriasis, and certain leukemias and lymphomas in adult patients.

GNH USA supplies Metoject Pen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate is a disease‑modifying antirheumatic drug (DMARD) that modulates immune activity in several chronic conditions.

- Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriasis: decreases skin plaque formation and severity. - Certain leukemias and lymphomas: interferes with malignant cell proliferation.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or vomiting - Fatigue - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Severe liver toxicity or hepatitis - Pulmonary fibrosis or interstitial pneumonitis - Significant bone marrow suppression leading to pancytopenia

What precautions apply to Methotrexate?

Metoject Pen requires careful monitoring and specific safety measures before and during therapy. - Pregnancy: Contraindicated (Category X) due to risk of fetal toxicity. - Breastfeeding: Not recommended; methotrexate can be excreted in milk. - Liver function: Baseline and periodic liver enzyme testing is essential. - Hematology: Regular complete blood counts to detect myelosuppression. - Renal impairment: Dose adjustment or avoidance in severe renal dysfunction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate interacts with several drug classes; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): May increase methotrexate toxicity by reducing renal clearance. - Penicillins (e.g., ampicillin): Can raise methotrexate serum levels and risk toxicity.

Moderate Interactions (Monitor Closely): - Sulfonamides: May enhance myelosuppression. - Live vaccines: Reduced efficacy and increased infection risk. - Proton pump inhibitors: May affect renal elimination; monitor methotrexate levels.

Frequently asked questions

What conditions is Metoject Pen used to treat?+
Metoject Pen contains methotrexate and is indicated for rheumatoid arthritis, moderate to severe plaque psoriasis, and certain hematologic malignancies such as specific leukemias and lymphomas. In each case, it helps control disease activity by reducing inflammation or inhibiting abnormal cell growth.
How does methotrexate work in the body?+
Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for producing tetrahydrofolate. Without tetrahydrofolate, cells cannot synthesize purines and pyrimidines needed for DNA and RNA, leading to reduced proliferation of immune cells and malignant lymphocytes, thereby exerting immunosuppressive and anticancer effects.
What determines the dose of Metoject Pen?+
The dose of Metoject Pen is individualized by the prescribing clinician based on the specific indication, disease severity, patient weight, renal function, and response to therapy. Patients should follow the exact dosing regimen provided by their healthcare professional.
Is Metoject Pen safe during pregnancy or breastfeeding?+
Metoject Pen is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy because it can cause fetal malformations or death. It is also not recommended during breastfeeding, as methotrexate can be transferred to the infant through milk.
How do I order Metoject Pen from GNH USA?+
To order Metoject Pen, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and any required import documentation.
How does Metoject Pen compare with other DMARDs such as leflunomide?+
Both methotrexate (Metoject Pen) and leflunomide are DMARDs used for rheumatoid arthritis, but methotrexate is generally considered first‑line due to extensive clinical experience and efficacy data. Leflunomide may be used when methotrexate is intolerable or contraindicated, though it carries its own hepatic and teratogenic risks.
What are the recommended storage conditions for Metoject Pen?+
Metoject Pen should be stored at 2‑8 °C (refrigerated). Keep the pen in its original packaging, protect it from light, and avoid freezing or shaking the device. Do not use the pen if it has been exposed to temperatures outside this range.
How is Metoject Pen administered?+
Metoject Pen is a pre‑filled, single‑use device for subcutaneous injection. After confirming the correct dose, the pen is placed against the skin (commonly the abdomen or thigh), the needle is activated, and the medication is delivered over a few seconds. Patients should be trained by a healthcare professional on proper technique.
What are the most serious risks associated with Metoject Pen?+
The most serious adverse events include severe liver toxicity, pulmonary fibrosis or interstitial pneumonitis, and profound bone‑marrow suppression leading to pancytopenia. These conditions require immediate medical attention and may necessitate discontinuation of therapy.
Who should not use Metoject Pen?+
Metoject Pen should be avoided in pregnant women, breastfeeding mothers, patients with severe renal or hepatic impairment, those with known hypersensitivity to methotrexate, and individuals receiving live vaccines. Clinicians must also assess risk in elderly patients and those with pre‑existing lung disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU